NL9401006A - Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. - Google Patents

Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. Download PDF

Info

Publication number
NL9401006A
NL9401006A NL9401006A NL9401006A NL9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A
Authority
NL
Netherlands
Prior art keywords
ibuprofen
treatment
salt
pharmaceutical composition
composition according
Prior art date
Application number
NL9401006A
Other languages
English (en)
Dutch (nl)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9401006A publication Critical patent/NL9401006A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL9401006A 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. NL9401006A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
ITMI931324 1993-06-21

Publications (1)

Publication Number Publication Date
NL9401006A true NL9401006A (nl) 1995-01-16

Family

ID=11366435

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9401006A NL9401006A (nl) 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.

Country Status (12)

Country Link
US (1) US5510385A (en:Method)
JP (1) JPH0710749A (en:Method)
BE (1) BE1007193A5 (en:Method)
CA (1) CA2125644C (en:Method)
CH (1) CH686866A5 (en:Method)
DE (1) DE4420858A1 (en:Method)
ES (1) ES2099022B1 (en:Method)
FR (1) FR2706891B1 (en:Method)
GB (1) GB2279251A (en:Method)
IT (1) IT1264855B1 (en:Method)
NL (1) NL9401006A (en:Method)
SE (1) SE9402156L (en:Method)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0740935A4 (en) * 1994-02-24 1999-06-16 Otsuka Pharma Co Ltd ANALGETIC ACTIVITY AMPLIFIER
NZ333474A (en) 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040241236A1 (en) * 2001-09-28 2004-12-02 Shun-Por Li Modified release dosage forms
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CA2519772C (en) 2003-03-21 2016-05-31 Mcneil-Ppc, Inc. Use of acetaminophen for providing a sustained therapeutic effect
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
BRPI0418885A (pt) * 2004-06-07 2007-11-27 Strides Arcolab Ltd composição farmacêutica contendo uma solução estável e clara de fármaco antiinflamatória em cápsula de gelatina mole e processo para a produção da mesma
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP2037898A2 (en) * 2006-06-30 2009-03-25 Mcneil-PPC, Inc Ibuprofen-containing liquid filled hard capsules
US8394415B2 (en) 2006-11-21 2013-03-12 Mcneil-Ppc, Inc Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
EP2630955B1 (en) * 2007-08-15 2021-09-22 Johnson & Johnson Consumer Inc. Immediate release and sustained release ibuprofen dosing regimen
US8143314B1 (en) * 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101265178A (zh) * 2008-04-25 2008-09-17 北京阜康仁生物制药科技有限公司 一种右旋布洛芬的氨基酸盐及其药用组合物
KR102225999B1 (ko) * 2008-12-04 2021-03-10 충시 위 고투과력을 가진 조성물 및 이의 적용
WO2010125212A1 (es) * 2009-04-27 2010-11-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Suspensión oral de lisinato de ibuprofeno
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
EP2594266B1 (en) * 2011-11-17 2014-07-30 Zambon S.p.A. Pharmaceutical solid compositions containing ibuprofen salts
US8900632B2 (en) 2012-02-07 2014-12-02 Mcneil-Ppc, Inc. Rapidly disintegrating coated tablets
US20140079796A1 (en) 2012-09-18 2014-03-20 Mcneil-Ppc, Inc. Sustained Release Oral Dosage Forms Comprising Low Melting Propionic Acid Derivative Particles
BR112015005876A2 (pt) 2012-09-18 2017-07-04 Mcneil Ppc Inc partículas derivadas de ácido propiônico com baixo ponto de fusão para uso em formas de dosagem oral
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CA3031474C (en) 2016-07-19 2025-07-08 Kenvue Brands Llc TABLETS WITH DISCONTINUOUS COATED AREAS
US11135266B2 (en) 2016-11-21 2021-10-05 Just-Evotec Biologics, Inc. Aflibercept formulations and uses thereof
US12178874B2 (en) 2017-11-20 2024-12-31 Just-Evotec Biologics, Inc. Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
US20190224129A1 (en) 2018-01-22 2019-07-25 Johnson & Johnson Consumer Inc. Perforated capsules
MY207573A (en) 2019-07-09 2025-03-05 Farmalder S A Combination of ibuprofen and tramadol for relieving pain
US20210378968A1 (en) 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
DE69022678T2 (de) * 1989-10-17 1996-03-21 Merck & Co Inc S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
EP0505180B1 (en) * 1991-03-22 1996-10-09 Merck & Co. Inc. High-content ibuprofen lysinate pharmaceutical formulation
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations

Also Published As

Publication number Publication date
ITMI931324A0 (it) 1993-06-18
ITMI931324A1 (it) 1994-12-21
JPH0710749A (ja) 1995-01-13
CA2125644A1 (en) 1994-12-22
BE1007193A5 (fr) 1995-04-18
DE4420858A1 (de) 1994-12-22
IT1264855B1 (it) 1996-10-17
FR2706891B1 (en:Method) 1995-10-20
SE9402156L (sv) 1994-12-22
CA2125644C (en) 2007-06-05
ES2099022A1 (es) 1997-05-01
SE9402156D0 (sv) 1994-06-20
US5510385A (en) 1996-04-23
ES2099022B1 (es) 1998-01-16
FR2706891A1 (en:Method) 1994-12-30
GB9410987D0 (en) 1994-07-20
CH686866A5 (it) 1996-07-31
GB2279251A (en) 1995-01-04

Similar Documents

Publication Publication Date Title
NL9401006A (nl) Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
RU2652345C2 (ru) Кетопрофеновая композиция для местного применения
RU2218180C2 (ru) Комбинация анальгетиков
CZ290646B6 (cs) Parenterální farmaceutické kompozice
Cattaneo et al. Clinical pharmacokinetics of ibuprofen arginine
NL194390C (nl) Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
NL9401005A (nl) Farmaceutische samenstelling met analgetische activiteit.
EP1377285A1 (en) Pharmaceutical composition comprising ibuprofen and prochlorperazine
EP4661867A1 (en) Compositions comprising n,n-dimethyltryptamine, optionally in combination with n-acylethanolamines and uses thereof
CN109803953A (zh) 药物制剂及其用途
KR20100031590A (ko) 광학 활성 Ｎ-(α-머캅토프로피오닐)글라이신
KR100567132B1 (ko) 이부프로펜과 아르기닌 함유 고농축 액상 조성물 및연질캡슐제
US4663345A (en) Etodolac for treatment of gout
KR100379155B1 (ko) 새로운 진통제 조성물
KR100523242B1 (ko) 이부프로펜을 함유하는 정제 조성물
EP4665327A1 (en) Compositions comprising 3,4-methylenedioxymethamphetamine, optionally in combination with n-acylethanolamines, and uses thereof
KR100986531B1 (ko) 액상의 아세클로페낙을 함유하는 캡슐제
WO2024171075A1 (en) Compositions comprising ibogaine, optionally in combination with n-acylethanolamines, and uses thereof
MXPA03012048A (es) Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
EP2965746B1 (en) An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
AU2008253125B2 (en) Oral dosage form providing fast absorption of drug
WO2025220686A1 (ja) ペプチド、糖脂肪酸エステル構造を有する界面活性剤及び（メタ）アクリル酸系ポリマーを含む医薬組成物
KR20240152875A (ko) L-트립토판, l-5-하이드록시트립토판 및 말초 분해 억제제를 포함하는 약학 조성물 및 약제
Lohare Ganesh et al. PERMEATION STUDIES OF NIMESULIDE FROM BUFFALO GHEE AS AN OLEAGINOUS BASE

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable